author-photo

Kimberly A. Kasow

University of North Carolina at Chapel Hill
St. Jude Children's Research Hospital

141

Papers

2052

Citations

Citation Trend

Filter By

Papers (141) Sort By

Journal Conference Others

Sustained Improvements in Patient-Reported Quality of Life up to 24 Months Post-Treatment with LentiGlobin for Sickle Cell Disease (bb1111) Gene Therapy

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
CD30-Directed Chimeric Antigen Receptor (CAR)-T Cells for Treatment of Hodgkin Lymphoma and Non-Hodgkin Lymphoma in Pediatric Patients

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Metabolomic Identification of Alpha-Ketoglutaric Acid Elevation in Pediatric Chronic Graft-versus-Host Disease.

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Resiliency during a COVID 19 Pandemic: The Quality Manager Perspective

2021
Show All
- Source
- Cite
- Save
Citations (0)
“Cleaning up the Confetti:” the Long-Term Financial Impact of Pediatric Hematopoietic Cell Transplantation

2021
Show All
- Source
- Cite
- Save
Citations (0)
Hematopoietic stem cell transplant referral patterns for children with sickle cell disease vary among pediatric hematologist/oncologists' practice focus: A Sickle Cell Transplant Advocacy and Research Alliance (STAR) study.

2021 Pediatric Blood & Cancer
Show All
- Source
- Cite
- Save
Citations (1)
Resolution of Serious Vaso-Occlusive Pain Crises: Results from the Ongoing Phase 1/2 HGB-206 Group C Study of LentiGlobin for Sickle Cell Disease (SCD; bb1111) Gene Therapy

2021
Show All
- Source
- Cite
- Save
Citations (0)
Mobility and Muscle Strength in Recipients of Hematopoietic Cell Transplantation for Sickle Cell Disease: A Preliminary Report from Sickle Transplant Evaluation of Longterm and Late Effects Registry (STELLaR)

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Outcomes of pediatric patients with therapy-related myeloid neoplasms.

2021 Bone Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (0)
Long-Term Quality of Life after Hematopoietic Cell Transplantation for Sickle Cell Disease: A Preliminary Report from the Sickle Cell Transplant Evaluation of Long Term and Late Effects Registry (STELLAR)

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)